Zhejiang Nhu Co Ltd
SZSE:002001

Watchlist Manager
Zhejiang Nhu Co Ltd Logo
Zhejiang Nhu Co Ltd
SZSE:002001
Watchlist
Price: 21.7 CNY -2.95% Market Closed
Market Cap: 65.9B CNY
Have any thoughts about
Zhejiang Nhu Co Ltd?
Write Note

Relative Value

The Relative Value of one Zhejiang Nhu Co Ltd stock under the Base Case scenario is 33.4 CNY. Compared to the current market price of 21.7 CNY, Zhejiang Nhu Co Ltd is Undervalued by 35%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
33.4 CNY
Undervaluation 35%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
79
vs Industry
31
Median 3Y
3.7
Median 5Y
4.2
Industry
2.5
Forward
3.2
vs History
71
vs Industry
22
Median 3Y
17.4
Median 5Y
16.6
Industry
21.9
Forward
12.8
vs History
96
vs Industry
32
Median 3Y
12.1
Median 5Y
13.5
Industry
16.5
vs History
71
vs Industry
2
Median 3Y
28.6
Median 5Y
26.2
Industry
23.6
vs History
38
vs Industry
31
Median 3Y
2.6
Median 5Y
2.5
Industry
2.1
vs History
82
vs Industry
28
Median 3Y
3.8
Median 5Y
4.5
Industry
2.6
Forward
3.4
vs History
74
vs Industry
14
Median 3Y
11.1
Median 5Y
10.5
Industry
5.2
vs History
77
vs Industry
19
Median 3Y
15
Median 5Y
14.3
Industry
13.3
Forward
8.1
vs History
77
vs Industry
22
Median 3Y
15
Median 5Y
14.3
Industry
16.6
Forward
12.7
vs History
98
vs Industry
30
Median 3Y
12.7
Median 5Y
14
Industry
15.6
vs History
55
vs Industry
8
Median 3Y
32.8
Median 5Y
20.5
Industry
19.1
vs History
38
vs Industry
35
Median 3Y
2.1
Median 5Y
2
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Zhejiang Nhu Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Zhejiang Nhu Co Ltd
SZSE:002001
66.7B CNY 3.4 14.5 12.6 12.6
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
CN
Zhejiang Nhu Co Ltd
SZSE:002001
Average P/E: 30.2
14.5
130%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top